Open Access
Volume 27, 2020
Article Number 31
Number of page(s) 7
Published online 12 May 2020

© C. Dard et al., published by EDP Sciences, 2020

Licence Creative CommonsThis is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Angiostrongylus cantonensis is a nematode parasite that is the leading cause of infectious eosinophilic meningitis in humans in tropical and sub-tropical regions [6]. The life cycle involves rats as definitive hosts (mainly Rattus spp.) [49], various gastropods as intermediate hosts, and crustaceans [23], fishes and various other species as paratenic hosts [6]. Human infection is accidental, by ingestion of stage 3 larvae (L3) in gastropods or in paratenic hosts [11]. Neuroangiostrongyliasis is commonly a self-limited meningitis syndrome, but a large spectrum of clinical manifestations is possible [5]. Clinical manifestations range from asymptomatic disease and mild headaches to radiculomyelitis and encephalitis that can lead to permanent neurological injury or even death [29]. Most human cases of neuroangiostrongyliasis have been recorded in East and Southeast Asia, and the Pacific Basin, but the disease appears to be emerging in Australia [1], South America [13, 32, 44], the United States [3, 21], and some islands of the Caribbean (Cuba, Haiti, Dominican Republic, Jamaica, and Guadeloupe) [12, 19, 42]. Several patients infected with A. cantonensis have been diagnosed with neuroangiostrongyliasis – but not reported in the scientific literature – during the last few years on the island of Martinique, a French overseas department in the Lesser Antilles with a population of 371,200 inhabitants as of 1 January 2018 (INSEE census, French National Institute of Statistics and Economic Studies, The objectives of this study were to estimate the incidence and assess the clinical and biological features of neuroangiostrongyliasis in Martinique.

Patients and methods

Study design

A retrospective single-centre observational study was undertaken at the University Hospital of Martinique – the main hospital on the island – spanning the period 1 January 2002 – 31 December 2017.

Inclusion and exclusion criteria

The following clinical and biological inclusion criteria were used: (i) neurological symptoms requiring lumbar puncture; (ii) eosinophilic meningitis defined as the presence of more than 10 eosinophils/mm3 in the cerebrospinal fluid (CSF) or ≥10% of the total CSF leukocyte count [5]; and (iii) detection of anti-A. cantonensis immunoglobulins in serum and/or CSF by indirect immunofluorescence assay (IIF) [22] or by western-blot (31-kDa antigen [34]). Patients with eosinophilia in the CSF due to a traumatic lumbar puncture or blood eosinophilia of another aetiology were excluded. Neuroangiostrongyliasis cases were defined as “confirmed” for patients who met the first two inclusion criteria, and with the detection of specific anti-A. cantonensis immunoglobulins in serum and/or CSF by western-blot. When A. cantonensis serology was found to be positive by IIF only, cases were defined as “probable” because of the low/lack of specificity of this method for nematode infections, in which some cross-reactions can be observed [47,48].

Data collection

Demographic data including exposure history, laboratory results (from blood and CSF), clinical presentation, imaging features (brain scan or MRI), and outcomes (recovery, sequelae, and death) were retrospectively collected from the medical charts, according to the legal and ethical guidelines of the French National Committee on Data Protection (CNIL).

Angiostrongylus cantonensis serology by indirect immunofluorescence assays

From 2002 to 2010, samples provided for A. cantonensis serological testing were sent to the only laboratory performing neuroangiostrongyliasis infection diagnosis in France, including its overseas regions (Laboratory of the Centre Hospitalier de Gonesse, Gonesse, France). An indirect immunofluorescence (IIF) assay was used for the detection of antibodies against A. cantonensis antigens, as described in [18]. Due to logistical constraints and availability of certain reagents, patient serodiagnosis in this laboratory ceased in 2010 and no other laboratory then performed the test in France. Subsequent serological analyses were therefore performed in Thailand or Switzerland by western-blot.

Angiostrongylus cantonensis serology by western-blot

Western blot assays using antigens derived from A. cantonensis adult worms were performed to detect IgG against A. cantonensis in either the Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, or the Swiss Tropical and Public Health Institute, Basel, Switzerland. The detection of the 31-kDa band confirmed serum positivity as it shows high sensitivity and specificity (>99% for both) for the diagnosis of A. cantonensis infections [17].


Descriptive results of the clinical presentations, including biological, imaging, and epidemiological features, are shown in Table 1 and statistically analyzed in Table 2. During the 16-year period of the study, four confirmed and four probable cases of neuroangiostrongyliasis were diagnosed in Martinique, among which three were children below 2 years of age, one was an 11-year-old boy, and four were adults aged from 37 to 64 years. The annual incidence rate was 0.14 cases/100,000 inhabitants/year (95% CI [0.04–0.23]) with six of the cases occurring during the rainy season from June to November. All patients were born and lived in Martinique and none reported recent travel. Contact with molluscs was reported in two cases. All five patients older than 2 years of age (Table 1) presented with pre-existing mental disorders (pica syndrome, bipolar disorder, intellectual disability, or autism), which may have promoted the accidental or even deliberate consumption of snails. All cases presented with acute neurological signs and/or symptoms requiring a lumbar puncture: dysfunction of the cranial nerves (highlighted by clinical neurological examination of the 12 pairs of cranial nerves), headaches, axial hypotonia, seizures, radiculalgia, and neck stiffness. Clinical examination was difficult for one patient because of autism. During hospitalisation, five patients had fever and three had digestive symptoms (vomiting, abdominal pain, loss of appetite, and/or diarrhoea). Brain imaging was performed for all patients (CT scan or MRI): five presented abnormalities, with abnormal enlargement of the cerebral ventricles or cortical atrophy, and three were normal. Blood eosinophilia at admission was inconsistent, with a median of 1.72 G/L (13% of the WBC count in blood) and a range of 0.49–6.43 G/L (5–31%). Median eosinophilia in the CSF at first lumbar puncture was 74.5 (25% of the WBC count in CSF), with a range of 0–1550/mm3 (4–68%) and the maximum values during hospitalisation were 373.5 (54.5%), with a range of 45–1550/mm3 (18–68%). Most patients were treated with albendazole [35] and/or corticosteroids [18]. Clinical outcomes ranged from rapid recovery without sequelae for two patients to neurological sequelae manifested as strabismus and intellectual disability for five patients. One case was fatal for a 58-year-old man. Diagnosis was made by anti-A. cantonensis antibody detection in sera for seven patients and confirmed positive in CSF for five of them. One patient only showed detectable anti-A. cantonensis antibodies in the CSF. Serological analysis was negative for two patients nine days after admission, but positive 19–38 days after admission.

Table 1

Description of the probable cases (numbers 1–4) and confirmed cases (numbers 5–8) of Angiostrongylus cantonensis infection in Martinique, including clinical, biological, imaging, and epidemiological features.

Table 2

Characteristics of the eight patients with eosinophilic meningitis caused by Angiostrongylus cantonensis.


This study reports the first eight laboratory-confirmed cases of neuroangiostrongyliasis in Martinique, which occurred between 2002 and 2017, thus extending the range of Caribbean islands with proven human cases of neuroangiostrongyliasis [12, 20, 44]. Given the potential lethality of neuroangiostrongyliasis, the medical community should therefore strongly consider the possibility of this infection in patients living in or returning from Martinique with eosinophilic meningitis.

In this study, neuroangiostrongyliasis cases occurred in two distinct epidemiological situations: three in infants less than 2 years old and five in patients over 11 years with mental diagnoses. The mode of transmission in infants was linked to poor living conditions with probable accidental consumption of contaminated snails or slugs when playing outside, as described on Mayotte, a French island in the Western Indian Ocean, in children under two years of age [18]. For adults, contamination was instead linked to intellectual disability associated with risky eating behaviour. In particular, pica syndrome may favour infection through the ingestion of gastropods usually not consumed as food in Martinique. No case was reported following consumption of raw paratenic hosts like shrimp, which is in contrast to the main source of infection in French Polynesia [35]. In our study, the diagnosis was initially unclear for all the patients and other kinds of helminthiases were initially suspected, as Martinique had never been reported as an endemic region for A. cantonensis. All but one of the patients were therefore treated with anti-helminthic drugs, although the efficacy and safety of albendazole or mebendazole for neuroangiostrongyliasis treatment remains controversial because of theoretical concerns that they may worsen the inflammatory response to dead and dying worms [5]. The four cases diagnosed after 2013 were also treated with corticosteroids, postulated to provide relief by reducing inflammation and thereby intracranial pressure and headache intensity [9, 43].

Comparison of the incidence of human neuroangiostrongyliasis in Martinique with neighbouring Caribbean Islands is straightforward. Indeed, cases were mainly reported in travellers returning from the Caribbean and it is likely that numerous autochthonous cases have not been reported in the scientific literature. Most Caribbean cases were reported in Cuba with several dozen cases since the 1980s [2, 36], mainly in the cities of Havana and Villa Clara [15, 16, 28, 37], and one case in a Swiss traveller returning from Cuba [7]. In Guadeloupe – another French West Indies island – four autochthonous cases were diagnosed (to our knowledge) between 1999 and 2017 in young children who may have been in contact with infected molluscs ([12] and unpublished data), corresponding to an annual incidence rate of 0.053 cases per inhabitant per year (95% CI [0.001–0.105]), close to that of Martinique. For the Dominican Republic, two suspected cases were reported in travellers returning to Europe [24, 41]. For Jamaica, twelve cases were diagnosed in adult travellers returning from Jamaica [38, 42], seven in autochthonous young children [19, 26] and one ocular case in a young woman [30]. No human cases have been reported in Grenada, the Bahamas, Haiti, and Puerto Rico, although A. cantonensis has been found in the environment on these islands [44]. It is noteworthy that the disease is also expanding in North and South America, in particular in the United States [27], Brazil [32], and some other South American countries [13, 44].

In this study, most cases occurred during the rainy season, during which snails abound, particularly the giant African snail, Lissachatina fulica, which was introduced to Martinique in 1989 [31] and is known elsewhere to act as an intermediate host of A. cantonensis. In Guadeloupe, A. cantonensis infection in A. fulica was 32.4% in 2014 [12]. No doubt other snail and slug species could also act as hosts as there are close to 90 non-marine mollusc species in Martinique [14, 23]. Numerous rodents have also been reported as potential definitive hosts of A. cantonensis worldwide [49]. Two species of rats, Rattus norvegicus (brown rat) and Rattus rattus (black rat), have been present in the territory since the late 18th century and probably play the role of definitive host of A. cantonensis in Martinique as they are the only rodent species in Martinique other than the mouse Mus musculus. No study has evaluated infection of rats with A. cantonensis in Martinique. In neighbouring Grenada [8, 10], Puerto Rico [4], Dominican Republic [45], Haiti [40], Jamaica [46], and Cuba [2], the proportion of infected Rattus spp. varies from 23.4% to 60.0% [2, 8], while the parasite appears to be absent in rats in Barbados [25].

Neuroangiostrongyliasis cases in Martinique seem particularly severe relative to other case-series reported in China and South-East Asia, with a higher mortality and sequelae rate. However, given the low number of cases, this must be confirmed as the number of neuroangiostrongyliasis cases increases in Martinique.

All cases were diagnosed by anti-A. cantonensis immunoglobulin detection in serum and/or CSF. Diagnosis was not performed by PCR as it was not available in Martinique or metropolitan France at the time of initial diagnosis [33] and no remaining CSF samples were available in our biobanks. In fact, molecular detection of A. cantonensis in CSF was developed in the early 2010s [48] and was only recently validated for clinical use [39]. The recent availability of a specific A. cantonensis PCR test in the French departments of South America and the Caribbean should improve the diagnosis of this disease in this region and encourage local authorities to undertake epidemiological studies on the intermediate and paratenic hosts and reservoirs, which should broaden our understanding of disease transmission in Martinique.


These authors contributed equally to this work.


We thank the physicians of the University Hospital of Martinique, including medical and clinical biologists, paediatricians, and neurologists for the initial diagnoses of neuroangiostrongyliasis. We thank the Direction de la Recherche Clinique et de l’Innovation (DRCI) of Martinique and the Parasitology–Mycology Laboratory of the University Hospital of Grenoble Alpes for their collaboration to the project “Angiostrongylus Research in French Antilles and Guiana”. We thank Dr. E. Vandemeulebroucke (Laboratory of Parasitology of the Hospital Centre of Gonesse, Gonesse, France) and Dr. Beatrice Nickel and Dr. Hanspeter Marti at the Swiss Tropical and Public Health Institute, Basel, Switzerland, for performing the serological analyses.

Conflict of interest

The authors declare that they have no conflict of interest.


  1. Aghazadeh M, Jones MK, Aland KV, Reid SA, Traub RJ, McCarthy JS, Lee R. 2015. Emergence of neural angiostrongyliasis in eastern Australia. Vector Borne and Zoonotic Diseases, 15, 184–190. [CrossRef] [Google Scholar]
  2. Aguiar PH, Morera P, Pascual J. 1981. First record of Angiostrongylus cantonensis in Cuba. American Journal of Tropical Medicine and Hygiene, 30, 963–965. [CrossRef] [Google Scholar]
  3. Al Hammoud R, Nayes SL, Murphy JR, Heresi GP, Butler IJ, Pérez N. 2017. Angiostrongylus cantonensis meningitis and myelitis, Texas, USA. Emerging Infectious Diseases, 23, 1037–1038. [CrossRef] [PubMed] [Google Scholar]
  4. Andersen E, Gubler DJ, Sorensen K, Beddard J, Ash LR. 1986. First report of Angiostrongylus cantonensis in Puerto Rico. American Journal of Tropical Medicine and Hygiene, 35, 319–322. [CrossRef] [Google Scholar]
  5. Ansdell V, Wattanagoon Y. 2018. Angiostrongylus cantonensis in travelers: clinical manifestations, diagnosis, and treatment. Current Opinion in Infectious Diseases, 31, 399–408. [CrossRef] [PubMed] [Google Scholar]
  6. Barratt J, Chan D, Sandaradura I, Malik R, Spielman D, Lee R, Marriott D, Harkness J, Ellis J, Stark D. 2016. Angiostrongylus cantonensis: a review of its distribution, molecular biology and clinical significance as a human pathogen. Parasitology, 143, 1087–1118. [CrossRef] [PubMed] [Google Scholar]
  7. Bärtschi E, Bordmann G, Blum J, Rothen M. 2004. Eosinophilic meningitis due to Angiostrongylus cantonensis in Switzerland. Infection, 32, 116–118. [Google Scholar]
  8. Chikweto A, Bhaiyat MI, Macpherson CNL, Deallie C, Pinckney RD, Richards C, Sharma RN. 2009. Existence of Angiostrongylus cantonensis in rats (Rattus norvegicus) in Grenada, West Indies. Veterinary Parasitology, 162, 160–162. [CrossRef] [PubMed] [Google Scholar]
  9. Chotmongkol V, Kittimongkolma S, Niwattayakul K, Intapan PM, Thavornpitak Y. 2009. Comparison of prednisolone plus albendazole with prednisolone alone for treatment of patients with eosinophilic meningitis. American Journal of Tropical Medicine and Hygiene, 81, 443–445. [CrossRef] [Google Scholar]
  10. Coomansingh-Springer C, Vishakha V, Acuna AM, Armstrong E, Sharma RN. 2019. Internal parasitic burdens in brown rats (Rattus norvegicus) from Grenada, West Indies. Heliyon, 5, e02382. [CrossRef] [PubMed] [Google Scholar]
  11. Cowie RH. 2013. Pathways for transmission of angiostrongyliasis and the risk of disease associated with them. Hawai’i Journal of Medicine & Public Health, 72(Supplement 2), 70–74. [Google Scholar]
  12. Dard C, Piloquet J-E, Qvarnstrom Y, Fox LM, M’kada H, Hebert J-C, Mattera D, Harrois D. 2017. First evidence of angiostrongyliasis caused by Angiostrongylus cantonensis in Guadeloupe, Lesser Antilles. American Journal of Tropical Medicine and Hygiene, 96(3), 692–697. [Google Scholar]
  13. Defo AL, Lachaume N, Cuadro-Alvarez E, Maniassom C, Martin E, Njuieyon F, Henaff F, Mrsic Y, Brunelin A, Epelboin L, Blanchet D, Harrois D, Desbois-Nogard N, Qvarnstrom Y, Demar M, Dard C, Elenga N. 2018. Angiostrongylus cantonensis infection of central nervous system, Guiana Shield. Emerging Infectious Diseases, 24, 1153–1155. [CrossRef] [PubMed] [Google Scholar]
  14. Delannoye R, Charles L, Pointier J-P, Massemin D. 2015. Non-marine molluscs of Martinique, Lesser Antilles, in Non-Marine Molluscs of Martinique. Lesser Antilles: Biotope Editions. [Google Scholar]
  15. Dorta-Contreras AJ. 2001. Eosinophilic meningoencephalitis in Cuba. Revista De Neurologia, 32, 999–1000. [CrossRef] [PubMed] [Google Scholar]
  16. Dorta-Contreras AJ, Núñez-Fernandez FA, Pérez-Martín O, Lastre-González M, Magraner-Tarrau ME, Bu-Coifiú Fanego R, Noris-García E, Padilla-Docal B, Interián-Morales MT, Martínez-Delgado JF, Sánchez-Zulueta E. 2007. Peculiarities of meningoencephalitis caused by Angiostrongylus cantonensis in America. Revista De Neurologia, 45, 755–763. [CrossRef] [PubMed] [Google Scholar]
  17. Eamsobhana P, Gan XX, Ma A, Wang Y, Wanachiwanawin D, Yong HS. 2014. Dot immunogold filtration assay (DIGFA) for the rapid detection of specific antibodies against the rat lungworm Angiostrongylus cantonensis (Nematoda: Metastrongyloidea) using purified 31-kDa antigen. Journal of Helminthology, 88, 396–401. [CrossRef] [PubMed] [Google Scholar]
  18. Epelboin L, Blondé R, Chamouine A, Chrisment A, Diancourt L, Villemant N, Atale A, Cadix C, Caro V, Malvy D, Collet L. 2016. Angiostrongylus cantonensis infection on Mayotte Island, Indian Ocean, 2007–2012. PLoS Neglected Tropical Diseases, 10, e0004635. [CrossRef] [PubMed] [Google Scholar]
  19. Evans-Gilbert T, Lindo JF, Henry S, Brown P, Christie CDC. 2013. Severe eosinophilic meningitis owing to Angiostrongylus cantonensis in young Jamaican children: case report and literature review. Paediatrics and International Child Health, 34(2), 148–152. [Google Scholar]
  20. Federspiel F, Skovmand S, Skarphedinsson S. 2020. Eosinophilic meningitis due to Angiostrongylus cantonensis in Europe. International Journal of Infectious Diseases, 93, 28–39. [CrossRef] [Google Scholar]
  21. Flerlage T, Qvarnstrom Y, Noh J, Devincenzo JP, Madni A, Bagga B, Hysmith ND. 2017. Angiostrongylus cantonensis eosinophilic meningitis in an Infant, Tennessee, USA. Emerging Infectious Diseases, 23, 1756–1758. [CrossRef] [PubMed] [Google Scholar]
  22. Graber D, Hebert JC, Jaffar-Bandjee MC, Alessandri JL, Combes JC. 1999. L’angiostrongylose chez le nourrisson à la Réunion et à Mayotte. À propos de trois méningites à éosinophiles dont une radiculomyéloencéphalite avec hydrocéphalie fatale. Bulletin de la Société de Pathologie Exotique, 90, 164–166. [Google Scholar]
  23. Kim JR, Hayes KA, Yeung NW, Cowie RH. 2014. Diverse gastropod hosts of Angiostrongylus cantonensis, the rat lungworm, globally and with a focus on the Hawaiian Islands. PloS One, 9, e94969. [CrossRef] [PubMed] [Google Scholar]
  24. Leone S, De Marco M, Ghirga P, Nicastri E, Esposito M, Narciso P. 2007. Eosinophilic meningitis in a returned traveler from Santo Domingo: case report and review. Journal of Travel Medicine, 14, 407–410. [CrossRef] [PubMed] [Google Scholar]
  25. Levett PN, Douglas KO, Douglas KA, Waugh CA, Robinson RD, Lindo JF. 2004. Failure to detect Angiostrongylus cantonensis in rats in Barbados. West Indian Medical Journal, 53, 58. [Google Scholar]
  26. Lindo JF, Escoffery CT, Reid B, Codrington G, Cunningham-Myrie C, Eberhard ML. 2004. Fatal autochthonous Eosinophilic meningitis in a Jamaican child caused by Angiostrongylus cantonensis. American Journal of Tropical Medicine and Hygiene, 70, 425–428. [CrossRef] [Google Scholar]
  27. Liu EW, Schwartz BS, Hysmith ND, DeVincenzo JP, Larson DT, Maves RC, Palazzi DL, Meyer C, Custodio HT, Braza MM, Al Hammoud R, Rao S, Qvarnstrom Y, Yabsley MJ, Bradbury RS, Montgomery SP. 2018. Rat Lungworm Infection Associated with Central Nervous System Disease – Eight U.S. States, January 2011–January 2017. Morbidity and Mortality Weekly Report (MMWR), 67, 825–828. [CrossRef] [Google Scholar]
  28. Martínez-Delgado JF, González-Cortiñas M, Tápanes-Cruz TR, Ruiz-Méndez A. 2000. Eosinophilic meningoencephalitis in Villa Clara (Cuba). A study of 17 patients. Revista De Neurologia, 31, 417–421. [CrossRef] [PubMed] [Google Scholar]
  29. Martins YC, Tanowitz HB, Kazacos KR. 2015. Central nervous system manifestations of Angiostrongylus cantonensis infection. Acta Tropica, 141, 46–53. [CrossRef] [PubMed] [Google Scholar]
  30. Mattis A, Mowatt L, Lue A, Lindo J, Vaughan H. 2009. Ocular angiostrongyliasis-first case report from Jamaica. West Indian Medical Journal, 58, 383–385. [Google Scholar]
  31. Mead A, Palcy L. 1992. Two giant African land snail species spread to Martinique, French West Indies. Veliger, 35, 74–77. [Google Scholar]
  32. Morassutti AL, Thiengo SC, Fernandez M, Sawanyawisuth K, Graeff-Teixeira C. 2014. Eosinophilic meningitis caused by Angiostrongylus cantonensis: an emergent disease in Brazil. Memórias do Instituto Oswaldo Cruz, 109, 399–407. [CrossRef] [Google Scholar]
  33. Nguyen Y, Rossi B, Argy N, Baker C, Nickel B, Marti H, Zarrouk V, Houzé S, Fantin B, Lefort A. 2017. Autochthonous case of eosinophilic meningitis caused by Angiostrongylus cantonensis, France, 2016. Emerging Infectious Diseases, 23, 1045–1046. [CrossRef] [PubMed] [Google Scholar]
  34. Nuamtanong S. 1996. The evaluation of the 29 and 31 kDa antigens in female Angiostrongylus cantonensis for serodiagnosis of human angiostrongyliasis. Southeast Asian Journal of Tropical Medicine and Public Health, 27, 291–296. [Google Scholar]
  35. Oehler E, Ghawche F, Delattre A, Berberian A, Levy M, Valour F. 2014. Angiostrongylus cantonensis eosinophilic meningitis: a clinical study of 42 consecutive cases in French Polynesia. Parasitology International, 63, 544–549. [CrossRef] [PubMed] [Google Scholar]
  36. Padilla-Docal B, Dorta-Contreras AJ, Moreira JM, Martini-Robles L, Muzzio-Aroca J, Alarcón F, Magraner-Tarrau ME, Bu-Coifiu-Fanego R. 2011. Comparison of major immunoglobulins intrathecal synthesis patterns in Ecuadorian and Cuban patients with angiostrongyliasis. American Journal of Tropical Medicine and Hygiene, 84, 406–410. [CrossRef] [Google Scholar]
  37. Pérez Martín O, Lastre González M, Duménigo Ripoll B, Aguiar Prieto PH, Aguilera A. 1984. Infestation by Angiostrongylus cantonensis in the Havana Provinces. Revista Cubana De Medicina Tropical, 36, 54–58. [PubMed] [Google Scholar]
  38. 2001. ProMED <>. Archive: 20011007.2426. International Society for Infectious Diseases. [Google Scholar]
  39. Qvarnstrom Y, Xayavong M, Aramburu da Silva AC, Park SY, Whelen AC, Calimlim PS, Sciulli RH, Honda SAA, Higa K, Kitsutani P, Chea N, Heng S, Johnson S, Graeff-Teixeira C, Fox LM, Da Silva AJ. 2015. Real-time polymerase chain reaction detection of Angiostrongylus cantonensis DNA in cerebrospinal fluid from patients with eosinophilic meningitis. American Journal of Tropical Medicine and Hygiene, 94(1), 176–181. [CrossRef] [Google Scholar]
  40. Raccurt CP, Blaise J, Durette-Desset M-C. 2003. Presence of Angiostrongylus cantonensis in Haiti. Tropical Medicine & International Health, 8, 423–426. [CrossRef] [Google Scholar]
  41. Rau C, Bialek R, Richter S, Lindner A. 2006. Headache after a stay in the Dominican Republic. Deutsche Medizinische Wochenschrift (1946), 131, 1656–1659. [CrossRef] [PubMed] [Google Scholar]
  42. Slom TJ, Cortese MM, Gerber SI, Jones RC, Holtz TH, Lopez AS, Zambrano CH, Sufit RL, Sakolvaree Y, Chaicumpa W, Herwaldt BL, Johnson S. 2002. An outbreak of eosinophilic meningitis caused by Angiostrongylus cantonensis in travelers returning from the Caribbean. New England Journal of Medicine, 346, 668–675. [CrossRef] [Google Scholar]
  43. Thanaviratananich S, Thanaviratananich S, Ngamjarus C. 2015. Corticosteroids for parasitic eosinophilic meningitis. Cochrane Database of Systematic Reviews, 2, CD009088. [Google Scholar]
  44. Valente R, Robles MDR, Navone GT, Diaz JI. 2018. Angiostrongylus spp. in the Americas: geographical and chronological distribution of definitive hosts versus disease reports. Memórias do Instituto Oswaldo Cruz, 113, 143–152. [CrossRef] [Google Scholar]
  45. Vargas M, Gomez Perez JD, Malek EA. 1992. First record of Angiostrongylus cantonensis (Chen, 1935) (Nematoda: Metastrongylidae) in the Dominican Republic. Tropical Medicine and Parasitology, 43, 253–255. [Google Scholar]
  46. Waugh CA, Lindo JF, Lorenzo-Morales J, Robinson RD. 2016. An epidemiological study of Angiostrongylus cantonensis in Jamaica subsequent to an outbreak of human cases of eosinophilic meningitis in 2000. Parasitology, 143, 1211–1217. [CrossRef] [PubMed] [Google Scholar]
  47. Welch JS, Dobson C, Campbell GR. 1980. Immunodiagnosis and seroepidemiology of Angiostrongylus cantonensis zoonoses in man. Transactions of the Royal Society of Tropical Medicine and Hygiene, 74, 614–623. [CrossRef] [PubMed] [Google Scholar]
  48. Wilkins PP, Qvarnstrom Y, Whelen AC, Saucier C, da Silva AJ, Eamsobhana P. 2013. The current status of laboratory diagnosis of Angiostrongylus cantonensis infections in humans using serologic and molecular methods. Hawai’i Journal of Medicine & Public Health, 72, 55–57. [Google Scholar]
  49. Yong HS, Eamsobhana P. 2013. Definitive rodent hosts of the rat lungworm Angiostrongylus cantonensis. Raffles Bulletin of Zoology, 29 (Supplement 29), 111–115. [Google Scholar]

Cite this article as: Dard C, Tessier E, Nguyen D, Epelboin L, Harrois D, Swale C, Cabié A, de Meuron K, Miossec C & Desbois-Nogard N. 2020. First cases of Angiostrongylus cantonensis infection reported in Martinique, 2002–2017. Parasite 27, 31.

All Tables

Table 1

Description of the probable cases (numbers 1–4) and confirmed cases (numbers 5–8) of Angiostrongylus cantonensis infection in Martinique, including clinical, biological, imaging, and epidemiological features.

Table 2

Characteristics of the eight patients with eosinophilic meningitis caused by Angiostrongylus cantonensis.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.